MORPHOLOGICAL PATTERNS OF ANEMIA AND TREATMENT APPROACHES IN PATIENTS WITH LIVER CIRRHOSIS ADMITTED TO A TERTIARY CARE MEDICAL UNIT

Main Article Content

Mashal
Muhammad Fawad
Sundas Mohmand
Umar Alim
Zahir Shah
Anwar Shahzad

Keywords

Liver cirrhosis, Anemia, Morphological patterns, Normocytic anemia, Microcytic anemia, Peripheral smear, Hematological abnormalities.

Abstract

Anemia is a common complication associated with liver cirrhosis; however, it is also a complication that is often underestimated. Several factors contribute to this issue, including malnutrition, chronic inflammatory processes, hypersplenism, and reduced activity of bone marrow. It is crucial to appreciate the variety of patterns of morphological manifestations of anemia present in this cohort of patients to ensure it is diagnosed in a timely manner, and to make sure the appropriate management can be instituted.


Methodology: This descriptive cross-sectional study was conducted in the Medical Unit of Gomal Medical College, Dera Ismail Khan, from January 2024 to January 2025. 72 adults with documented liver cirrhosis were included through consecutive sampling. Demographic data, clinical data, complete blood counts, and data from peripheral smears were collected. Anemia was classified as normocytic, microcytic, macrocytic, or dimorphic according to red cell indices and smear variables. Therapeutic measures administered during the patients' hospital stays were also documented.


Results: Normocytic anemia emerged as the most common morphological type, followed by microcytic and macrocytic patterns, while dimorphic anemia was observed in a smaller proportion. Associations between anemia patterns and selected laboratory parameters showed significant variation, with lower hemoglobin and albumin levels more frequently seen in patients with microcytic and dimorphic anemia. These findings highlight the multifactorial nature of anemia in cirrhosis and its relationship with disease severity.


Conclusion: The findings of the research are such that among cirrhotic patients, normocytic anemia is of primary concern, although the microcytic and macrocytic patterns also play a considerable role. These patterns serve a purpose in guiding the clinician toward nutritional deficit recognition, occult blood loss, or bone marrow suppression, in a timely manner for more directives to be managed. Assessing the anemia pattern in cirrhosis is of great importance in aiding the medical professional in improving the clinical decision, more so, the overall patient's condition.

Abstract 0 | PDF Downloads 0

References

1. Rahman, M.M., et al., Abnormal haematological indices in cirrhosis in a tertiary Care Hospital. 2022. 7(11): p. 555-557.
2. Marginean, C.M., et al., Diagnostic approach and pathophysiological mechanisms of anemia in chronic liver disease—an overview. 2023. 14(3): p. 327-341.
3. Tariq, T., et al., National trends and outcomes of nonautoimmune hemolytic anemia in alcoholic liver disease: Analysis of the Nationwide Inpatient Sample. 2021. 55(3): p. 258-262.
4. Rashidi-Alavijeh, J., et al., Implications of anaemia and response to anaemia treatment on outcomes in patients with cirrhosis. 2023. 5(4): p. 100688.
5. Scheiner, B., et al., Prevalence of and risk factors for anaemia in patients with advanced chronic liver disease. 2020. 40(1): p. 194-204.
6. Singh, S., et al., Association of liver cirrhosis severity with anemia: does it matter? 2020. 33(3): p. 272.
7. Manrai, M., et al., Anemia in cirrhosis: An underestimated entity. 2022. 10(3): p. 777.
8. Randi, M.L., et al., Prevalence and causes of anemia in hospitalized patients: impact on diseases outcome. 2020. 9(4): p. 950.
9. Timerga, A., K. Haile, and S.J.P.o. Dessu, Anemia and associated factors among patients admitted with metabolic syndromes at Worabe Comprehensive Specialized Hospital, Southern Ethiopia: A cross-sectional study. 2022. 17(4): p. e0266089.
10. Bianco, C., et al., Diagnosis and management of autoimmune hemolytic anemia in patients with liver and bowel disorders. 2021. 10(3): p. 423.
11. Gulea, C., R. Zakeri, and J.K.J.B.m. Quint, Model-based comorbidity clusters in patients with heart failure: association with clinical outcomes and healthcare utilization. 2021. 19(1): p. 9.
12. Wadehra, A., et al., Rapidly Progressive Acute Liver Failure in Relapsed Multiple Myeloma. 2020. 12(12).
13. Njoroge, J.N. and J.R.J.C.r. Teerlink, Pathophysiology and therapeutic approaches to acute decompensated heart failure. 2021. 128(10): p. 1468-1486.
14. Kakkar, B., et al., Transfusion practices in cirrhotic patients at a tertiary liver care center from Northern India. 2021. 43(03): p. 280-286.
15. Mu, X.-M., et al., Patterns of comorbidity in hepatocellular carcinoma: a network perspective. 2020. 17(9): p. 3108.
16. Argano, C., et al., Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry. 2021. 16(2): p. 389-400.
17. Singer, C.E., et al., Role of iron deficiency in heart failure—clinical and treatment approach: An overview. 2023. 13(2): p. 304.
18. Metawea, M.I., et al., COVID 19 and liver: An A–Z literature review. 2021. 53(2): p. 146-152.
19. Bishaw, F., et al., Prevalence of anemia and its predictors among patients with chronic kidney disease admitted to a teaching hospital in Ethiopia: A hospital-based cross-sectional study. 2023. 102(6): p. e31797.
20. Marques, O., G. Weiss, and M.U.J.B. Muckenthaler, The Journal of the American Society of Hematology, The role of iron in chronic inflammatory diseases: from mechanisms to treatment options in anemia of inflammation. 2022. 140(19): p. 2011-2023.

Most read articles by the same author(s)